Dimethylamine

Dimethylamine

SCHEMBL5887339

CNC.COCCNc1nc(C)c2ccc(=O)n(-c3ccc(C(=O)NCCCO)cc3)c2n1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 4/20 0.45
MAPK9 P45984 4/20 0.45
MAPK10 P53779 4/20 0.45
ALDH1A1 P00352 7/20 0.39
POLB P06746 2/20 0.38
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
RAB9A P51151 3/20 0.36
KDM4E B2RXH2 3/20 0.36
NPC1 O15118 2/20 0.36
HSD17B10 Q99714 3/20 0.36
MEN1 O00255 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
RECQL P46063 1/20 0.35
GLA P06280 2/20 0.35
GAA P10253 2/20 0.35
HPGD P15428 2/20 0.35
TP53 P04637 1/20 0.35
CASP1 P29466 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL5887112 0.90 MAPK8 (0.39) MAPK8MAPK9MAPK10POLBMAPT
SCHEMBL5886760 0.90 L3MBTL1 (0.43) MAPK8MAPK9MAPK10ALDH1A1MAPT
Dimethylamine SCHEMBL5887379 0.90 MAPT (0.46) MAPK8MAPK9MAPK10ALDH1A1POLB
SCHEMBL5886803 0.89 ALDH1A1 (0.41) MAPK8MAPK9MAPK10ALDH1A1POLB
SCHEMBL5886801 0.87 MAPK8 (0.38) MAPK8MAPK9MAPK10ALDH1A1POLB
Dimethylamine SCHEMBL5887456 0.87 MAPK8 (0.44) MAPK8MAPK9MAPK10ALDH1A1MAPT
Dimethylamine SCHEMBL5887677 0.86 MAPT (0.42) MAPK8MAPK9MAPK10POLBMAPT
SCHEMBL5887014 0.86 CDK5 (0.39) MAPK8MAPK9MAPK10ALDH1A1MAPT
SCHEMBL5886736 0.85 MAPK8 (0.46) MAPK8MAPK9MAPK10ALDH1A1POLB
Dimethylamine SCHEMBL5887416 0.85 TDP1 (0.41) MAPK8MAPK9MAPK10ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US claimed
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors PHARMACIA ITALIA S.P.A. 2004-01-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors TERT, TERF2, TERF2IP MAPK8 770/4885MAPK9 640/4885MAPK10 1723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.